DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming

Alexander B.H. Bakker, Robert M. Hoek, Adelheid Cerwenka, Bianca Blom, Linda Lucian, Tom McNeil, Richard Murray, Joseph H. Phillips, Jonathon D. Sedgwick, Lewis L. Lanier

Research output: Contribution to journalArticleAcademicpeer-review

204 Citations (Scopus)

Abstract

DAP12 is an ITAM-bearing membrane adaptor molecule implicated in the activation of NK and myeloid cells. In mice rendered DAP12 deficient by targeted gene disruption, lymphoid and myeloid development was apparently normal, although the activating Ly49 receptors on NK cells were downregulated and nonfunctional. To analyze the consequences of DAP12 deficiency in vivo, we examined the susceptibility of DAP12(-/-) mice to experimental autoimmune encephalomyelitis (EAE). DAP12(-/-) mice were resistant to EAE induced by immunization with myelin oligodendrocyte glycoprotein (MOG) peptide. Resistance was associated with a strongly diminished production of IFNγ by myelin-reactive CD4+ T cells due to inadequate T cell priming in vivo. These data suggest that DAP12 signaling may be required for optimal antigen-presenting cell (APC) function or inflammation.

Original languageEnglish
Pages (from-to)345-353
Number of pages9
JournalImmunity
Volume13
Issue number3
DOIs
Publication statusPublished - 2000

Cite this